Command Palette

Search for a command to run...

VAISHALI

11.01-0.45%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Vaishali Pharma Ltd. displays concerning metrics with no revenue growth, earnings, or efficiency indicators, placing it at the bottom of the peer comparison. In contrast, Sun Pharmaceutical Industries and Cipla Ltd. stand out as sector leaders with strong profitability and growth metrics. Companies like Divi's Laboratories and Torrent Pharmaceuticals present mixed results but may indicate potential value picks for further scrutiny.

Key Points
  • Vaishali Pharma Ltd. shows no growth or profitability metrics, indicating financial strain.
  • Sun Pharmaceutical and Cipla lead in profitability with strong ROE and profit margins.
  • Companies with high valuations include Sun Pharma and Divi's Labs, which may be overvalued given their growth rates.
  • Cipla and Dr. Reddy's Labs display low PEG ratios, suggesting they may be undervalued for their growth potential.
Top Performers
Sun Pharmaceutical Industries Ltd.

Highest EPS and ROE, showing strong profitability and growth.

Cipla Ltd.

Strong revenue growth and solid profitability metrics.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.